Designing a Local Policy to Reduce HIV in Mexico City

Abstract

The Joint United Nations Program on human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) (Joint United Nations Program on HIV/AIDS, UNAIDS) has recommended 90–90–90 goals to increase the number of patients who are aware of their status, on antiretroviral therapy, and have undetectable viral loads. Mexico City has made several achievements to aid in prevention, early diagnosis, and treatment; however, the incidence of HIV has not decreased over the past decade. This article reviews global initiatives that were successful in achieving some or all these metrics and provide a road map for Mexico to reach the desired goals.

Keywords

HIV - Mexico - strategy - prevention - early treatment

Publication History

Article published online:
29 August 2023

• References

• 1 UNAIDS. Country- Mexico. Available at: Accessed August 17, 2023 at: https://www.unaids.org/en/regionscountries/countries/mexico
• 2 Secretaría de Salud. Sistema de Vigilancia Epidemiológica de VIH Informe Histórico de VIH 2do Trimestre. 2021 . Available at: Accessed August 17, 2023 at: https://www.gob.mx/cms/uploads/attachment/file/667817/VIH-Sida_2doTrim_2021.pdf
• 3 IHME. GBD Compare / Viz Hub. Available at: Accessed August 17, 2023 at: https://vizhub.healthdata.org/gbd-compare/
• 4 Colchero MA, Cortés-Ortiz MA, Romero-Martínez M. et al. HIV prevalence, sociodemographic characteristics, and sexual behaviors among transwomen in Mexico City. Salud Publica Mex 2015; 57 (Suppl. 02) s99-s106
• 5 Bautista-Arredondo S, Servan-Mori E, Beynon F, González A, Volkow P. A tale of two epidemics: gender differences in socio-demographic characteristics and sexual behaviors among HIV positive individuals in Mexico City. Int J Equity Health 2015; 14 (01) 147
• 6 Bautista-Arredondo S, Colchero MA, Romero M, Conde-Glez CJ, Sosa-Rubí SG. Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men. PLoS One 2013; 8 (09) e72616
• 7 Torres-Ruiz A. HIV/AIDS and sexual minorities in Mexico: a globalized struggle for the protection of human rights. Lat Am Res Rev 2011; 46 (01) 30-53
• 8 International Association of Providers of AIDS Care. 90–90–90 Target Update. July 21, 2019 . Mexico City. Available at: Accessed August 17, 2023 at: https://www.iapac.org/conferences/90-90-90-targets-workshop/
• 9 UNAIDS. 90–90–90 An ambitious treatment target to help end the AIDS epidemic. Available at: Accessed August 17, 2023 at: https://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf
• 10 UNAIDS. Miles To Go Closing Gaps Breaking Barriers Righting Injustices. Available at: Accessed August 17, 2023 at: https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf
• 11 Rousseau E, Bekker LG, Julies RF. et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Serv Res 2021; 21 (01) 888
• 12 Dave S, Peter T, Fogarty C, Karatzas N, Belinsky N, Pant Pai N. Which community-based HIV initiatives are effective in achieving UNAIDS 90-90-90 targets? A systematic review and meta-analysis of evidence (2007-2018). PLoS One 2019; 14 (07) e0219826
• 13 MacKellar D, Williams D, Bhembe B. et al. Peer-delivered linkage case management and same-day ART initiation for men and young persons with HIV infection—Eswatini, 2015–2017. MMWR Morb Mortal Wkly Rep 2018; 67 (23) 663-667
• 14 Behforouz HL, Farmer PE, Mukherjee JS. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis 2004; 38 (Suppl. 05) S429-S436
• 15 U.S. Food & Drug Administration. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. Available at: Accessed August 17, 2023 at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention
• 16 Smith DK, Van Handel M, Wolitski RJ. et al. Vital signs: estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition—United States, 2015. MMWR Morb Mortal Wkly Rep 2015; 64 (46) 1291-1295
• 17 Scarsi KK, Swindells S. The promise of improved adherence with long-acting antiretroviral therapy: what are the data?. J Int Assoc Provid AIDS Care 2021;20:23259582211009011(JIAPAC)
• 18 U.S. Food & Drug Administration. FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV. Available at: Accessed August 17, 2023 at: https://www.fda.gov/news-events/press-announcements/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv
• 19 Vilalta CJ. Fear of crime in public transport: research in Mexico City. Crime Prev Community Saf 2011; 13 (03) 171-186
• 20 Reuters. Mexican official resigns as HIV drug shortage sparks outcry. Available at: Accessed August 17, 2023 at: https://www.reuters.com/article/us-mexico-aids-drug/mexican-official-resigns-as-hiv-drug-shortage-sparks-outcry-idUSKCN1SF2E7